Axsome Therapeutics, Inc. (AXSM)
206.91
+4.08
(+2.01%)
USD |
NASDAQ |
Sep 02, 13:41
Axsome Therapeutics Net Income (TTM) : -191.64M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -191.64M |
| March 31, 2026 | -188.30M |
| December 31, 2025 | -183.17M |
| September 30, 2025 | -229.53M |
| June 30, 2025 | -246.90M |
| March 31, 2025 | -278.27M |
| December 31, 2024 | -287.22M |
| September 30, 2024 | -310.96M |
| June 30, 2024 | -308.55M |
| March 31, 2024 | -296.38M |
| December 31, 2023 | -239.24M |
| September 30, 2023 | -201.83M |
| June 30, 2023 | -184.45M |
| March 31, 2023 | -158.72M |
| December 31, 2022 | -187.13M |
| September 30, 2022 | -159.87M |
| June 30, 2022 | -149.93M |
| March 31, 2022 | -140.78M |
| December 31, 2021 | -130.40M |
| September 30, 2021 | -125.59M |
| Date | Value |
|---|---|
| June 30, 2021 | -113.63M |
| March 31, 2021 | -99.68M |
| December 31, 2020 | -102.90M |
| September 30, 2020 | -98.54M |
| June 30, 2020 | -94.75M |
| March 31, 2020 | -90.19M |
| December 31, 2019 | -68.35M |
| September 30, 2019 | -53.14M |
| June 30, 2019 | -42.28M |
| March 31, 2019 | -36.80M |
| December 31, 2018 | -30.97M |
| September 30, 2018 | -28.80M |
| June 30, 2018 | -26.95M |
| March 31, 2018 | -25.75M |
| December 31, 2017 | -28.94M |
| September 30, 2017 | -28.84M |
| June 30, 2017 | -29.60M |
| March 31, 2017 | -29.33M |
| December 31, 2016 | -27.20M |
| September 30, 2016 | -21.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Eli Lilly & Co. | 26.71B |
| Liquidia Corp. | 138.61M |
| Filana Therapeutics, Inc. | -42.28M |
| CorMedix, Inc. | 187.17M |
| Eloxx Pharmaceuticals, Inc. | -13.74M |